Lactobacillus reuteri (L. reuteri) treatment attenuated E. coli-induced mastitis by promoting tryptophan metabolism and activating AhR, leading to reduced NF-κB activation and improved barrier function in mice [68]. This evidence concerns the gene NFKB1 and mastitis.